| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bronchodilator reversibility in patients with asthma and persistent airflow limitation
|
Crisafulli, Ernesto
|
|
|
10 |
11 |
p. e94-e95
|
artikel
|
| 2 |
Bronchodilator reversibility in patients with asthma and persistent airflow limitation – Authors' reply
|
Kole, Tessa M
|
|
|
10 |
11 |
p. e96
|
artikel
|
| 3 |
Correction to Lancet Respir Med 2022; published online Aug 18. https://doi.org/10.1016/S2213-2600(22)00226-0
|
|
|
|
10 |
11 |
p. e106
|
artikel
|
| 4 |
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial
|
Love, Nicola K
|
|
|
10 |
11 |
p. 1074-1085
|
artikel
|
| 5 |
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
|
Shaw, Robert H
|
|
|
10 |
11 |
p. 1049-1060
|
artikel
|
| 6 |
European Respiratory Society International Congress 2022
|
Venkatesan, Priya
|
|
|
10 |
11 |
p. e103-e104
|
artikel
|
| 7 |
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
|
Shi, Yuankai
|
|
|
10 |
11 |
p. 1019-1028
|
artikel
|
| 8 |
Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis
|
Lacasse, Yves
|
|
|
10 |
11 |
p. 1029-1037
|
artikel
|
| 9 |
Implications of court ruling on preventive services in the USA
|
Nelson, Roxanne
|
|
|
10 |
11 |
p. e105
|
artikel
|
| 10 |
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study
|
Hodgson, Carol L
|
|
|
10 |
11 |
p. 1038-1048
|
artikel
|
| 11 |
Lifting the veil on humour and anaesthetics
|
Ranscombe, Peter
|
|
|
10 |
11 |
p. 1017
|
artikel
|
| 12 |
Long-term oxygen therapy in COPD: what is the evidence?
|
Windisch, Wolfram
|
|
|
10 |
11 |
p. 1010-1011
|
artikel
|
| 13 |
Monkeypox transmission—what we know so far
|
Venkatesan, Priya
|
|
|
10 |
11 |
p. e101
|
artikel
|
| 14 |
More investment needed to tackle NCDs
|
Cooper, Bethany
|
|
|
10 |
11 |
p. e102
|
artikel
|
| 15 |
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
|
Hakki, Seran
|
|
|
10 |
11 |
p. 1061-1073
|
artikel
|
| 16 |
Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome
|
Wick, Katherine D
|
|
|
10 |
11 |
p. 1086-1098
|
artikel
|
| 17 |
SARS-CoV-2: can isolation be limited to those who are truly infectious?
|
Vink, Elen
|
|
|
10 |
11 |
p. 1011-1013
|
artikel
|
| 18 |
Tackling the global burden of lung disease through prevention and early diagnosis
|
Agusti, Alvar
|
|
|
10 |
11 |
p. 1013-1015
|
artikel
|
| 19 |
The burden of tuberculosis in Libya
|
Balakrishnan, Vijay Shankar
|
|
|
10 |
11 |
p. e99-e100
|
artikel
|
| 20 |
The long shadow of COVID-19 in Africa
|
Makoni, Munyaradzi
|
|
|
10 |
11 |
p. 1016
|
artikel
|
| 21 |
The upcoming influenza season and protection from vaccines
|
Burki, Talha
|
|
|
10 |
11 |
p. 1018
|
artikel
|
| 22 |
When should we treat moderate hypoxaemia in patients with COPD?
|
Attaway, Amy
|
|
|
10 |
11 |
p. e97
|
artikel
|
| 23 |
When should we treat moderate hypoxaemia in patients with COPD? – Authors' reply
|
Lacasse, Yves
|
|
|
10 |
11 |
p. e98
|
artikel
|
| 24 |
Withdrawal of COVID funding compounds health inequalities
|
The Lancet Respiratory Medicine,
|
|
|
10 |
11 |
p. 1009
|
artikel
|
Tijdschrift beschrijving